Mark Frasier - Concepedia

Author

Mark Frasier

Also Known As

Adrienne Clark, Brit Mollenhauer, Frasier, M., Frasier, Mark, Karl Kieburtz, M FRASIER, M Frasier, M. Frasier, Mark A Frasier, Mark A. Frasier

Publications

7.6K

Citations

H-Index

Concepts

All Affiliations

Michael J. Fox Foundation National Institute on Aging University of Pennsylvania National Institutes of Health Institute for Neurodegenerative Disorders

About

Mark Frasier is an author at Michael J. Fox Foundation specializing in medicine, neurodegenerative diseases, and neurology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	10	1.4K
2	Engineering	3	3	171
3	Natural Sciences	1	1	163
4	Public Health	1	1	216
5	Biochemistry	1	1	163

Mark Frasier

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort Kenneth Marek, Sohini Chowdhury, Andrew Siderowf, Annals of Clinical and Translational Neurology	2018	633
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study Andrew Siderowf, Luis Concha‐Marambio, David-Erick Lafontant, The Lancet Neurology Neurodegenerative DiseasesDisease ProgressionParkinson DiseaseNeurologyMedicine	2023	618
Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease Kuldip D. Dave, Shehan De Silva, Niketa P. Sheth, Neurobiology of Disease	2014	225
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study Mike A. Nalls, Cory Y. McLean, Jacqueline Rick, The Lancet Neurology Disease DiagnosisNeurological DisorderMedicineParkinson DiseaseGenetic Epidemiology	2015	216
Magnesium Inhibits Spontaneous and Iron-induced Aggregation of α-Synuclein Natalie Golts, Heather M. Snyder, Mark Frasier, Journal of Biological Chemistry	2002	209
Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort Tanya Simuni, Andrew Siderowf, Shirley Lasch, Movement Disorders	2018	199
Loss of Leucine-Rich Repeat Kinase 2 (LRRK2) in Rats Leads to Progressive Abnormal Phenotypes in Peripheral Organs Marco A. S. Baptista, Kuldip D. Dave, Mark Frasier, PLoS ONE	2013	183
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression Brit Mollenhauer, Mohammed Dakna, Niels Kruse, Movement Disorders	2020	183
Mitochondrial associated metabolic proteins are selectively oxidized in A30P α-synuclein transgenic mice—a model of familial Parkinson's disease H. Fai Poon, Mark Frasier, Nathan Shreve, Neurobiology of Disease Neurodegenerative DiseasesMetabolic ProteinsBiochemistryMitochondrial FunctionFamilial Parkinson	2005	163
Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls Brit Mollenhauer, Chelsea Caspell‐Garcia, Christopher S. Coffey, Neurology	2017	149

Page 1